Drug Approval | April 14, 2025
Aurolife Pharma gets 11 observations from USFDA for Raleigh plant
The company does not expect this development to have any material impact on the current business operations
The company does not expect this development to have any material impact on the current business operations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
Ibara will drive AI-powered clinical research innovation
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Subscribe To Our Newsletter & Stay Updated
